Cardiovascular risk factors and hyperinsulinemia in elderly men: The Honolulu Heart Program

Annals of Epidemiology

Volumn 6, Issue 6, 1996, Pages 490-497

  Burchfiel, Cecil M ^a,e   Curb, J David ^b,c   Arakaki, Richard ^c   Abbott, Robert D ^d   Sharp, Dan S ^a   Rodriguez, Beatriz L ^b,c   Yano, Katsuhiko ^b  

^a Honolulu Epidemiology Research Unit   (United States)

^b KUAKINI MEDICAL CENTER   (United States)

^c UNIVERSITY OF HAWAII   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Asian Americans; insulin; obesity; risk factors

Indexed keywords

AGED; ARTICLE; ASIAN AMERICAN; BODY MASS; CARDIOVASCULAR RISK; DRUG USE; GLUCOSE BLOOD LEVEL; HEART RATE; HEMATOCRIT; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; UNITED STATES;

EID: 0030292808     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1047-2797(96)00103-2     Document Type: Article

References (49)

1. 1. Stern MP. The insulin resistance syndrome: The controversy is dead, long live the controversy! Diabetologia. 1994;37:956-958.
2. 2. Pyorala K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: Results from two population studies in Finland. Diabetes Care. 1979;2:131-141.
3. 3. Welborn TA, Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care. 1979;2:154-160.
4. 4. Ducimetier P, Eschwege R, Papoz L, Richard JL, Claude JR, Rosselin G. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia. 1980;19:205-210.
5. 5. Welin L, Eriksson H, Larsson B, Ohlson LO, Svardsudd K, Tibblin G. Hyperinsulinaemia is not a major coronary risk factor in elderly men: The study of men born in 1913. Diabetologia. 1992;35:766-770.
6. 6. Hargreaves AD, Logan RL, Elton RA, Buchanan KD, Oliver MF, Riemersmaa RA. Glucose tolerance, plasma insulin, HDL cholesterol and obesity: 12-year follow-up and development of coronary heart disease in Edinburgh men. Atherosclerosis. 1992;94:61-69.
7. 7. Ferrara A, Barrett-Connor EL, Edelstein SL. Hyperinsulinemia does not increase the risk of fatal cardiovascular disease in elderly men or women without diabetes: The Rancho Bernardo Study, 1984-1991. Am J Epidemiol. 1994;140:857-869.
8. 8. Burke GL, Webber LS, Srinivasan SR, Radhakrishnamurthy B, Freedman DS, Berenson GS. Fasting plasma glucose and insulin levels and their relationship to cardiovascular risk factors in children: Bogalusa Heart Study. Metabolism. 1986;35:441-446.
9. 9. Manolio TA, Savage PJ, Burke GL, et al. Correlates of fasting insulin levels in young adults: The CARDIA Study. J Clin Epidemiol. 1991;44:571-578.
10. 10. Zavaroni I, Bonora E, Pagliara M, et al. Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med. 1989;320:702-706.
11. 11. Burchfiel CM, Shetterly SM, Baxter J, Hamman RF. The roles of insulin, obesity and fat distribution in the elevation of cardiovascular risk factors in impaired glucose tolerance: The San Luis Valley Diabetes Study. Am J Epidemiol. 1992;136:1101-1109.
12. 12. Haffner SM, Fong D, Hazuda HP, Pugh JA, Patterson JK. Hyperinsulinemia, upper body obesity, and cardiovascular risk in non-diabetics. Metabolism. 1988;37:338-345.
13. 13. Nabulsi AA, Folsom AR, Heiss G, et al. Fasting hyperinsulinemia and cardiovascular disease risk factors in nondiabetic adults: Stronger associations in lean versus obese subjects. Metabolism. 1995;44: 914-922.
14. 14. Mykkanen K, Laakso M, Pyorala K. High plasma insulin level associated with coronary heart disease in the elderly. Am J Epdiemiol. 1993;137:1190-1202.
15. 15. Feskens EJM, Kromhout D. Hyperinsulinemia, risk factors, and coronary heart disease: the Zutphen Elderly Study. Arterioscler Thromb. 1994;14:1641-1647.
16. 16. Burchfiel CM, Curb JD, Sharp DS, et al. Distribution and correlates of insulin in elderly men: The Honolulu Heart Program. Arterioscler, Thromb, Vasc Biol. 1995;15:2213-2221.
17. 17. Stout RW. Insulin and atheroma: 20-yr perspective. Diabetes Care. 1990;13:631-654.
18. 18. Flack JM, Sowers JR. Epidemiologic and clinical aspects of insulin resistance and hyperinsulinemia. Am J Med 1991;91(suppl 1A): 11S-21S.
19. 19. Kaplan NM. The deadly quartet: Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med. 1989;149:1514-1520.
20. 20. Simonson DC. Hyperinsulinemia and its sequelae. Horm Metab Res. 1990;22(suppl):17-25.
21. 21. Eckel RH. Insulin resistance: An adaptation for weight maintenance. Lancet. 1992;340:1452-1453.
22. 22. Clausen JO, Hansen T, Bjorbaek C, et al. Insulin resistance: Interactions between obesity and a common variant of insulin receptor substrate-1. Lancet 1995;346:397-402.
23. 23. Worth RM, Kagan A. Ascertainment of men of Japanese ancestry in Hawaii through World War II Selective Service registration. J Chronic Dis. 1970;23:389-397.
24. 24. Rhoads GG, Kagan AM, Yano K. Usefulness of community surveillance for the ascertainment of coronary heart disease and stroke. Int J Epidemiol. 1975;4:265-270.
25. 25. Yano K, Reed DM, McGee DL. Ten-year incidence of coronary heart disease in the Honolulu Heart Program: Relationship to biological and life-style characteristics. Am J Epidemiol. 1984;119:653-666.
26. 26. Burchfiel CM, Sharp DS, Curb JD, et al. Physical activity and incidence of diabetes: The Honolulu Heart Program. Am J Epidemiol. 1995;141:360-368.
27. 27. Ferris BG. Epidemiology standardization project. Am Rev Respir Dis. 1978(6, part 2):55-38.
28. 28. American Thoracic Society. Standardization of spirometry: 1987 update. Am Rev Respir Dis. 1987;136:1285-1298.
29. 1 in Japanese-American men from 45 to 68 years of age. Am Rev Respir Dis. 1988;138:1393-1397.
30. 30. Ettinger WH, Wahl PW, Kuller LH, et al. Lipoprotein lipids in older people: Results from the Cardiovascular Health Study. Circulation. 1992;86:858-869.
31. 31. Fried LP, Borhani NO, Enright P, et al. The Cardiovascular Health Study: Design and Rationale. Ann Epidemiol. 1991;1:263-276.
32. 32. Morgan CR, Lazarov A. Immunoassay of insulin: Two antibody systems. Diabetes. 1963;21:115-126.
33. 33. World Health Organization. Diabetes Mellitus: Report of a WHO Study Group, WHO technical report series No. 727. Geneva, Switzerland: World Health Organization;1985.
34. 34. SAS Institute, Inc. SAS/STAT User's Guide, Version 6. Cary, NC: SAS Institute, Inc;1990.
35. 35. Williams B. Insulin resistance: The shape of things to come. Lancet. 1994;344:521-524.
36. 36. Reaven GM, Laws A. Insulin resistance, compensatory hyperinsulinaemia, and coronary heart disease. Diabetologia. 1994;37:948-952.
37. 37. Reaven GM. Banting Lecture 1988: Role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
38. 38. Ferrannini E, Haffner SM, Mitchell BD, Stern MP. Hyperinsulinaemia: The key feature of a cardiovascular and metabolic syndrome. Diabetologia. 1991;34:416-422.
39. 39. Stern MP, Morales PA, Haffher SM, Valdez RA. Hyperdynamic circulation and the insulin resistance syndrome, ("syndrome X"). Hypertension. 1992;20:802-808.
40. 40. Jarrett RJ. Epidemiology and public health aspects of non-insulin-dependent diabetes mellitus. Epidemiol. Rev. 1989;11:151-171.
41. 41. Eliasson B, Attvall S, Taskinen M-R, Smith U. The insulin resistance syndrome in smokers is related to smoking habits. Arterioscler Thromb. 1994;14:1946-1950.
42. 42. Facchini FS, Hollenbeck CB, Jeppesen J, Chen Y-DI, Reaven GM. Insulin resistance and cigarette smoking. Lancet. 1992;339:1128-1130.
43. 43. Moller LF, Jespersen J. Elevated insulin levels in men: An 11-year follow-up study. J Cardiovasc Risk. 1995;2:339-343.
44. 44. Orchard TJ, Elchner J, Kuller LH, Backer DJ, McCallum LM, Gradits GA. Insulin as a predictor of coronary heart disease: Interaction with apolipprotein E phenotype. Ann Epidemiol. 1994;4:40-45.
45. 45. Stern MP, Haffner SM. Body fat distribution and hyperinsulinemia as risk factors for diabetes and cardiovascular disease. Arteriosclerosis. 1986;6:123-130.
46. 46. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes. 1992;41:715-722.
47. 47. Modan M, Halkin H, Almog S, et al. Hyperinsulinemia: A link between hypertension, obesity and glucose intolerance. J Clin Invest. 1985;75:809-817.
48. 48. Godsland IF, Stevenson JC. Insulin resistance: Syndrome or tendency? Lancet. 1995;346:100-103.
49. 49. Despres J-P, Marette A. Relation of components of insulin resistance syndrome to coronary disease risk. Curr Opin Lipidol. 1994;5:274-289.